MX2021016108A - Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea. - Google Patents

Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.

Info

Publication number
MX2021016108A
MX2021016108A MX2021016108A MX2021016108A MX2021016108A MX 2021016108 A MX2021016108 A MX 2021016108A MX 2021016108 A MX2021016108 A MX 2021016108A MX 2021016108 A MX2021016108 A MX 2021016108A MX 2021016108 A MX2021016108 A MX 2021016108A
Authority
MX
Mexico
Prior art keywords
diseases
pharmaceutical combination
treating infectious
infectious respiratory
air
Prior art date
Application number
MX2021016108A
Other languages
English (en)
Inventor
Hernandez Gustavo Barranco
Arroyo Hector Senosiain
Original Assignee
Alparis Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De Cv filed Critical Alparis Sa De Cv
Priority to MX2021016108A priority Critical patent/MX2021016108A/es
Priority to PCT/IB2022/062339 priority patent/WO2023111967A1/es
Publication of MX2021016108A publication Critical patent/MX2021016108A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe el uso de una combinación que comprende curcumina y arginina para el tratamiento de enfermedades infecciosas, incluyendo enfermedades respiratorias y enfermedades infecciosas adquirida por vía aérea. La presente invención también se refiere a una composición farmacéutica, incluyendo una composición de administración nasal, que comprende curcumina y arginina, útil para el tratamiento de dichas enfermedades.
MX2021016108A 2021-12-17 2021-12-17 Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea. MX2021016108A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2021016108A MX2021016108A (es) 2021-12-17 2021-12-17 Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.
PCT/IB2022/062339 WO2023111967A1 (es) 2021-12-17 2022-12-16 Combinación farmacéutica para el tratamiento de la infección respiratoria causada por el sars-cov-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2021016108A MX2021016108A (es) 2021-12-17 2021-12-17 Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.

Publications (1)

Publication Number Publication Date
MX2021016108A true MX2021016108A (es) 2023-06-19

Family

ID=86773901

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021016108A MX2021016108A (es) 2021-12-17 2021-12-17 Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.

Country Status (2)

Country Link
MX (1) MX2021016108A (es)
WO (1) WO2023111967A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303328B1 (en) * 2008-05-29 2017-12-20 Universite Libre De Bruxelles Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
MX2019010692A (es) * 2019-09-06 2022-07-06 Alparis Sa De Cv Compuestos de curcumina y aminoácidos básicos.

Also Published As

Publication number Publication date
WO2023111967A1 (es) 2023-06-22

Similar Documents

Publication Publication Date Title
WO2019157099A8 (en) Intranasal epinephrine formulations and methods for the treatment of disease
MX2016012766A (es) Sistema y metodo para suministro de gas terapeutico a pacientes en necesidad del mismo usando la medicion de flujo de gas de circuito de respiracion (bcg) mejorada.
CY1119216T1 (el) Φαρμακευτικη συνθεση για εισπνοη
PH12020551709A1 (en) Antiviral immunotropic agent for the treatment of acute respiratory viral infections
ATE531415T1 (de) Verneblermaske zur verabreichung von aerosol- und vernebelten medikamenten
MX2019002541A (es) Derivados de pirimidina contra virus de la influenza.
CR10112A (es) Enmascaramiento del sabor de polvos.
MX2019003988A (es) Formulaciones de nanoparticulas y sus metodos de fabricacion y uso.
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
MX2019003099A (es) Composicion farmaceutica.
MX2016010723A (es) Mascarilla laringea.
EP3962661A4 (en) NASAL MEDICATION DELIVERY DEVICES AND METHODS
AU2018278840A1 (en) Combination devices, systems, and methods for humidification of the airways and high efficiency delivery of pharmaceutical aerosols
GB202000254D0 (en) An efficient drug delivery device based on the respiratory medicine department
MX2021016108A (es) Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.
EA201991265A1 (ru) Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат
BR112017014861A2 (pt) ?combinação e composição farmacêuticas, inalador de pó seco, uso de uma combinação farmacêutica, e, método para tratamento de um distúrbio pulmonar?
MX2018009948A (es) Formulaciones de oritavancina.
FI4197528T3 (fi) Koostumuksia, menetelmiä ja järjestelmiä aerosolilääkkeen antamiseen
CY1125762T1 (el) Νεα απο του στοματος σκευασματα βελινοστατης
EP3806766A4 (en) DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING THE NASAL CAVITY
EP3765072A4 (en) 3,5-DIALCOXYBENZOYL-3'-AMINO-3'-DEOXYADENOSINE-5'-TRIPHOSPHATE AND THEIR PHARMACEUTICAL USES THEREOF
TR201712424A2 (tr) Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
AU2019903887A0 (en) Nasal CPAP Mask and System thereof
MX2021015449A (es) Vector recombinante y composicion inmunogenica para la prevencion de la enfermedad causada por virus sincitial respiratorio.